Cargando…
YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer
YKL-39 belongs to the evolutionarily conserved family of Glyco_18-containing proteins composed of chitinases and chitinase-like proteins. Chitinase-like proteins (CLPs) are secreted lectins that lack hydrolytic activity due to the amino acid substitutions in their catalytic domain and combine the fu...
Autores principales: | Kzhyshkowska, Julia, Larionova, Irina, Liu, Tengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988383/ https://www.ncbi.nlm.nih.gov/pubmed/32038607 http://dx.doi.org/10.3389/fimmu.2019.02930 |
Ejemplares similares
-
Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
por: Liu, Tengfei, et al.
Publicado: (2018) -
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis
por: Larionova, Irina, et al.
Publicado: (2021) -
Monocyte programming by cancer therapy
por: Patysheva, Marina, et al.
Publicado: (2022) -
Expression of Osteoarthritis Marker YKL-39 is Stimulated by Transforming Growth Factor Beta (TGF-beta) and IL-4 in Differentiating Macrophages
por: Gratchev, Alexei, et al.
Publicado: (2008) -
Interaction of tumor-associated macrophages and cancer chemotherapy
por: Larionova, Irina, et al.
Publicado: (2019)